DeepMed Research

University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Neural Mechanisms for Stopping Ongoing Speech Production

Not Applicable

Conditions: Speech
Epilepsy

Interventions: Behavioral: Speech Production Tasks

First Posted Date: 2023-05-26

Last Posted Date: 2024-10-07

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 30

Registration Number: NCT05876910

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Improving HIV Adherence Care for Key Populations in India

Not Applicable

Active, not recruiting

Conditions: Treatment Adherence

Interventions: Behavioral: KP Specific Wellness Sessions
Behavioral: Peer Navigation

First Posted Date: 2023-05-22

Last Posted Date: 2025-05-13

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 110

Registration Number: NCT05869461

Locations: 🇮🇳
The Humsafar Trust, Mumbai, India

The Heart Rhythm Twins Study

Active, not recruiting

Conditions: Premature Atrial Complex
Premature Ventricular Contraction

First Posted Date: 2023-05-19

Last Posted Date: 2025-05-06

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 120

Registration Number: NCT05866731

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

A Closed Loop, Doctor to Patient, Mobile Application for Depression in People With Multiple Sclerosis

Not Applicable

Recruiting

Conditions: MS
Depression
Multiple Sclerosis

Interventions: Behavioral: MS CATCH

First Posted Date: 2023-05-18

Last Posted Date: 2024-02-20

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 100

Registration Number: NCT05865405

Locations: 🇺🇸
Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California, United States

The Outreach and Prevention at ALcohol Venues in East Africa Study (OPAL-East Africa- Aim 1)

Not Applicable

Completed

Conditions: HIV/AIDS

Interventions: Behavioral: HIV-focused mobilization
Behavioral: Multi-disease-focused mobilization

First Posted Date: 2023-05-17

Last Posted Date: 2025-04-01

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 7727

Registration Number: NCT05862857

Locations: 🇺🇬
Infectious Diseases Research Collaboration (IDRC), Mbarara, Uganda
🇰🇪
Kenya Medical Research Institute (KEMRI), Mbita, Kenya

Optimizing Mindfulness Based Cognitive Therapy (MBCT) Maintenance

Not Applicable

Completed

Conditions: Depression

Interventions: Behavioral: Mindfulness maintenance program

First Posted Date: 2023-05-16

Last Posted Date: 2024-07-03

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 34

Registration Number: NCT05859386

Locations: 🇺🇸
UCSF, San Francisco, California, United States

Molecular Signatures of Cutaneous Dupilumab Response

Phase 4

Recruiting

Conditions: Atopic Dermatitis

Interventions: Drug: Dupilumab

First Posted Date: 2023-05-15

Last Posted Date: 2024-06-27

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 15

Registration Number: NCT05858619

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Immune Spatial Features of Guselkumab Cutaneous Response

Phase 4

Recruiting

Conditions: Psoriasis of Scalp

Interventions: Drug: Guselkumab

First Posted Date: 2023-05-15

Last Posted Date: 2023-08-28

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 10

Registration Number: NCT05858632

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

Correction of Psoriatic T Cell Signatures by Deucravacitinib

Phase 4

Recruiting

Conditions: Psoriasis Vulgaris

Interventions: Drug: deucravacitinib

First Posted Date: 2023-05-15

Last Posted Date: 2024-06-27

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 25

Registration Number: NCT05858645

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest

Phase 2

Recruiting

Conditions: Heart Arrest
Refractory Status Epilepticus
Hypoxia-Ischemia, Brain
Seizures
Anoxia-Ischemia, Cerebral
Anoxic-Ischemic Encephalopathy
Status Epilepticus

Interventions: Drug: Burst Suppression EEG Target Intravenous Anesthesia
Drug: Seizure Suppression EEG Target Intravenous Anesthesia

First Posted Date: 2023-05-09

Last Posted Date: 2025-05-15

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 30

Registration Number: NCT05851391

Locations: 🇺🇸
Zuckerberg San Francisco General Hospital, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy